Peptide screening reveals irreversible inhibitors for cancer's 'undruggable' cJun protein
For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...
Targeted Oncology31 分钟
Targeting ESR1 Mutations in Breast Cancer With Novel Therapies
Seth Wander, MD, PhD, discusses approved and upcoming targeted therapies for patients with ESR1-mutated breast cancer.